Lead designated Market Access Strategy Teams for a portfolio of oncology assets across solid tumors and hematological malignancies, with a focus on prostate cancer and multiple myeloma
Job Summary
Lead designated Market Access Strategy Teams for a portfolio of oncology assets across solid tumors and hematological malignancies, with a focus on prostate cancer and multiple myeloma.
Develop comprehensive market access strategies for products in portfolio, including public and private market reimbursement strategic plans to support asset value proposition for decision makers and payers.
Co-lead evidence generation process with Medical Affairs to support data generation requirements for the products within portfolio.
Matching Summary
Lead designated Market Access Strategy Teams for a portfolio of oncology assets across solid tumors and hematological malignancies, with a focus on prostate cancer and multiple myeloma.
Salary
Base: 162,750.00- 212,750.00; Bonus/Equity: discretionary performance bonus; Benefits: Not specified
Skills & Requirements
Must-have
Market Access Strategy Teams
oncology assets
reimbursement strategic plans
evidence generation process
negotiation strategies
payer engagement
Nice-to-have
strong business insight
innovative ideas
creative problem-solving
collaboration across organization
Key Requirements
Undergraduate degree in life sciences, pharmacy, economics or health service sciences
5+ years of Market Access experience
In-depth understanding of pharmaceutical lifecycle management
In-depth knowledge of health technology assessment
Experience with Canadian payers and key opinion leaders